Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618 1631 1633 1672 1684 1687
This examiner grants 50% of resolved cases
Joseph T. Woitach is a patent examiner in Tech Center 1600 and Art Unit 1618. The examiner has 399 resolved cases. The allowance rate for these cases is 49.9 percent. This percentage represents the proportion of applications that reach a grant. The 399 resolved cases provide a factual basis for understanding the examiner's history in this art unit.
The interview lift is 28.3 percent. This figure indicates the difference in allowance probability for cases that include an interview. The median days to allowance is 1702. This number shows the time from filing to grant for successful applications. Practitioners can use the 49.9 percent allowance rate and the 1702 median days to allowance to set expectations for the prosecution process. These data points offer a grounded view of the examiner's actions. The interview lift of 28.3 percent is a statistical measure of the impact of direct communication during the examination of patent applications.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17443917 | METHODS, SYSTEMS, AND COMPUTER-READABLE MEDIA FOR CALCULATING CORRECTED AMPLICON COVERAGES | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17351068 | Laser Capture Microdissection Systems and Method for Image Analysis | Non-Final OA | Life Technologies Corporation |
| 17411889 | SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCE ASSEMBLY | Non-Final OA | 10x Genomics, Inc |
| 16115373 | METHODS AND SYSTEMS FOR EVALUATING TUMOR MUTATIONAL BURDEN | Final Rejection | Genentech, Inc. |
| 18556737 | ANALYSIS OF FRAGMENT ENDS IN DNA | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 17733866 | Method for Determining Relatedness of Genomic Samples Using Partial Sequence Information | Non-Final OA | The Regents of the University of California |
| 17828488 | IMPLANT PLANNING AND GUIDANCE WITH SOFT TISSUE ASSESSMENT | Non-Final OA | MAKO Surgical Corp. |
| 17523764 | EVALUATION METHOD, STORAGE MEDIUM, AND EVALUATION DEVICE | Final Rejection | FUJITSU LIMITED |
| 17835821 | NON-INVASIVE DIAGNOSIS OF GRAFT REJECTION IN ORGAN TRANSPLANT PATIENTS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17665345 | DYNAMIC SCHEDULING SYSTEM AND METHOD OF DYEING PROCESS USING GENETIC ALGORITHM | Final Rejection | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE |
| 17356614 | COVER SET DETERMINATION FOR IDENTIFYING BIOLOGICAL ENTITIES | Non-Final OA | International Business Machines Corporation |
| 16002329 | METHOD FOR PREDICTING AUTISM | Final Rejection | RENSSELAER POLYTECHNIC INSTITUTE |
| 17692606 | METHOD FOR ACQUIRING INFORMATION ON SPINAL MUSCULAR ATROPHY | Final Rejection | SYSMEX CORPORATION |
| 17724296 | METHODS AND SYSTEMS FOR MULTIPLE TAXONOMIC CLASSIFICATION | Non-Final OA | University of Utah Research Foundation |
| 17552728 | METHODS TO DETERMINE TUMOR GENE COPY NUMBER BY ANALYSIS OF CELL-FREE DNA | Non-Final OA | GUARDANT HEALTH, INC. |
| 17000010 | DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS | Final Rejection | GUARDANT HEALTH, INC. |
| 15431395 | DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS | Non-Final OA | Guardant Health, Inc. |
| 17872980 | SYSTEM AND METHOD FOR MANAGING CONTROL DATA FOR OPERATION OF BIOSYSTEMS ON CHIPS | Final Rejection | Dell Products L.P. |
| 18217812 | ENCODING AN ASSEMBLY OF THREE-DIMENSIONAL HIERARCHICALLY ORGANIZED NANOPARTICLE ARCHITECTURES THROUGH CHROMATIC BONDS | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17963732 | Allelotyping Methods for Massively Parallel Sequencing | Non-Final OA | Battelle Memorial Institute |
| 16579500 | SYSTEM AND METHOD FOR MANAGING GENOMIC INFORMATION | Final Rejection | FOUNDATION MEDICINE, INC. |
| 16269980 | Method for Evaluating Genotoxicity of Substance | Final Rejection | Kao Corporation |
| 16306213 | METHOD FOR DETECTING A TARGET ANALYTE IN A SAMPLE USING A SIGNAL CHANGE-AMOUNT DATA SET | Final Rejection | SEEGENE, INC. |
| 17547297 | METHODS AND SYSTEMS FOR VISUALIZING SHORT READS IN REPETITIVE REGIONS OF THE GENOME | Final Rejection | Illumina, Inc. |
| 17400165 | SAMPLE ANALYZER FOR ANALYZING NUCLEIC ACID SEQUENCING DATA | Non-Final OA | Illumina, Inc. |
| 17348212 | METHODS AND SYSTEMS FOR ANALYZING IMAGE DATA | Non-Final OA | Illumina, Inc. |
| 17339598 | ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS | Non-Final OA | Peptilogics, Inc. |
| 17904573 | METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION | Final Rejection | The United States of America, as represented by the Secretary, Dept. of Health and Human Services |
| 17520037 | METHODS AND SYSTEMS FOR GENOME ANALYSIS | Non-Final OA | University of Utah |
| 17581788 | NEOANTIGEN IDENTIFICATION USING HOTSPOTS | Non-Final OA | Gritstone bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy